Catheter Precision Files Proxy Statement

TL;DR

Catheter Precision (CPTR) filed its proxy statement, standard procedure for shareholder votes.

AI Summary

Catheter Precision, Inc. filed a Definitive Proxy Statement (DEFA14A) on September 4, 2025. This filing is soliciting material under Rule 14a-12, indicating it's related to a proxy solicitation. The company, formerly known as Ra Medical Systems, Inc. until September 8, 2017, is based in Fort Mill, SC.

Why It Matters

This filing is a standard regulatory document that provides shareholders with information regarding company matters, often related to upcoming shareholder votes or meetings.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEFA14A) and does not inherently present new financial risks.

Key Players & Entities

• Catheter Precision, Inc. (company) — Registrant
• Ra Medical Systems, Inc. (company) — Former company name
• 0001716621 (company) — Central Index Key
• 3841 (company) — Standard Industrial Classification
• 383661826 (company) — EIN
• DE (company) — State of Incorporation
• 1231 (company) — Fiscal Year End
• 001-38677 (company) — SEC File Number
• 251293710 (company) — Film Number
• 1670 HIGHWAY 160 WEST SUITE 205 (company) — Business Address

FAQ

Filing Documents

• vtak20250904_defa14a.htm (DEFA14A) — 16KB
• 0001437749-25-028375.txt ( ) — 17KB

From the Filing

vtak20250904_defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a 6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a12 Catheter Precision, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 011. On September 4, 2025, Catheter Precision, Inc. Issued the following press release: Catheter Precision Announces September 10 th , 2025 Record Date for October 10 th , 2025 Special Meeting of Stockholders Fort Mill, SC, September 4, 2025 – Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that September 10 th , 2025, is the Record Date for the October 10 th Special Meeting of the stockholders. We are seeking stockholder approval to amend our Certificate of Incorporation to increase our authorized shares of common stock, and stockholder ratification of the appointment of WithumSmith+Brown, PC as our independent auditor for our fiscal year 2026. Additional details are available in the preliminary proxy statement anticipated to be filed with the SEC on September 4 th , 2025. About Catheter Precision Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. Cautionary Note Regarding Forward-Looking Statements The forward-looking statements included in this communication are made only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law. Important Additional Information and Where to Find It Catheter Precision, Inc. (the " Company " ) plans to file proxy materials with the U.S. Securities and Exchange Commission (the " SEC " ) in connection with the solicitation of proxies for the Company ' s October 10, 2025 special meeting of stockholders (the " 2025 Special Meeting " ). Stockholders will be able to obtain, free of charge, copies of the Preliminary and Definitive Proxy Statement, any amendments or supplements thereto and any other documents (including the proxy card) when filed by the Company with the SEC at the SEC ' s website (http://www.sec.gov) or at the Company ' s website (https://www.catheterprecision.com). Certain Information Regarding Participants in the Solicitation The Company, its directors and certain of its executive officers and other employees may be deemed to be " participants " (as defined in Section 14(a) of the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from stockholders in connection with the 2025 Special Meeting. Information regarding the identity of these potential participants and their direct or indirect interests, by security holdings or otherwise, will be set forth in the Proxy Statement and other materials to be filed with the SEC in connection with the 2025 Special Meeting. CONTACTS: Investor Relations 973-691-2000 IR@catheterprecision.com # # #

View Full Filing

View this DEFA14A filing on SEC EDGAR